Susceptibility of urinary tract bacteria to fosfomycin.
We evaluated the in vitro activity of fosfomycin against urinary isolates in a region in Greece that exhibits considerable antimicrobial resistance by evaluating retrospectively relevant susceptibility data retrieved from the microbiological library of the University Hospital of Heraklion, Crete, Greece. We examined 578 urinary isolates. In total, 516 (89.2%) were susceptible to fosfomycin; 415 isolates were gram negative, and 101 isolates were gram positive. Fosfomycin appears to exhibit good levels of in vitro activity against the examined urinary isolates.
Maraki
Sofia
S
Department of Clinical Microbiology, University Hospital of Heraklion, Heraklion, Crete, Greece.
Samonis
George
G
Rafailidis
Petros I
PI
Vouloumanou
Evridiki K
EK
Mavromanolakis
Emmanuel
E
Falagas
Matthew E
ME
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D005578:Fosfomycin / Q000494:pharmacology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D014551:Urinary Tract / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D005578:Fosfomycin
Arch Intern Med. 2008 Sep 22;168(17):1897-902
18809817
Int J Antimicrob Agents. 2002 Jun;19(6):554-6
12135847
Ann Epidemiol. 2003 Feb;13(2):144-50
12559674
J Infect. 2008 Sep;57(3):179-84
18707763
Eur J Clin Microbiol Infect Dis. 2008 Jun;27(6):439-43
18214558
Rev Esp Quimioter. 2009 Mar;22(1):25-9
19308743
Presse Med. 2008 May;37(5 Pt 1):746-50
18329234
Am J Med. 2002 Jul 8;113 Suppl 1A:5S-13S
12113866
Curr Opin Investig Drugs. 2009 Feb;10(2):172-80
19197795
Am J Med. 2008 Oct;121(10):876-84
18823859
Rev Invest Clin. 2007 Jul-Aug;59(4):239-45
18019596
Diagn Microbiol Infect Dis. 2007 Dec;59(4):439-45
17888610
J Urol. 2005 Apr;173(4):1281-7
15758783
Int J Antimicrob Agents. 2003 Oct;22 Suppl 2:79-83
14527776
J Antimicrob Chemother. 2009 Sep;64(3):454-89
19587067
Clin Microbiol Rev. 2007 Jul;20(3):440-58, table of contents
17630334
Curr Med Res Opin. 2008 Dec;24(12):3423-34
19032124
Clin Infect Dis. 2008 Apr 1;46(7):1069-77
18444827
Int J Antimicrob Agents. 2009 Aug;34(2):111-20
19403273
Eur J Clin Microbiol Infect Dis. 2009 Jan;28(1):61-8
18682995
J Chemother. 2008 Dec;20(6):721-7
19129070
Ann Intern Med. 1989 Dec 1;111(11):906-17
2683922
J Antimicrob Chemother. 2006 Mar;57(3):551-6
16436541
Antimicrob Agents Chemother. 2006 Jan;50(1):368-70
16377714
Clin Infect Dis. 2008 Nov 1;47(9):1150-8
18808361
Clin Infect Dis. 1999 Oct;29(4):745-58
10589881
Ann Pharmacother. 1998 Feb;32(2):215-9
9496408
Obstet Gynecol. 2008 Mar;111(3):785-94
18310389
Drugs. 1997 Apr;53(4):637-56
9098664
Clin Ther. 2008 Oct;30(10):1859-68
19014841
Expert Opin Investig Drugs. 2009 Jul;18(7):921-44
19548851
Pol Przegl Chir. 1976 Dec;48(12):1491-4
1005244
Rev Esp Quimioter. 2007 Jun;20(2):206-10
17893757
Int J Immunopathol Pharmacol. 2008 Jan-Mar;21(1):153-60
18336741
Pathol Biol (Paris). 2003 Oct;51(8-9):503-7
14568598
J Clin Microbiol. 2008 Aug;46(8):2605-12
18579721
Med Mal Infect. 2008 Jul;38(7):383-6
18550311